DUNCAN JASON (General Counsel) received a stock award from ALBIREO PHARMA, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/25/2023ACC: 0001209191-23-004950
Officer· General Counsel
Since Jan 2019
+55K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
55K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+55K
Price / share
—
Trade value
—
% of position
388.8%
1/19/2023
14.15K→69.15K
Total
Net shares
+55K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/19/2023 | A · Award | +55K | — | — | 388.8% | 14.15K | 69.15K |
| Total | +55K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported